These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25539763)

  • 1. ALCAM is indirectly modulated by miR-125b in MCF7 cells.
    Akman HB; Selcuklu SD; Donoghue MT; Akhavantabasi S; Sapmaz A; Spillane C; Yakicier MC; Erson-Bensan AE
    Tumour Biol; 2015 May; 36(5):3511-20. PubMed ID: 25539763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-148a and miR-152 reduce tamoxifen resistance in ER+ breast cancer via downregulating ALCAM.
    Chen MJ; Cheng YM; Chen CC; Chen YC; Shen CJ
    Biochem Biophys Res Commun; 2017 Feb; 483(2):840-846. PubMed ID: 28063929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of ALCAM expression is linked to adverse phenotype and poor prognosis in breast cancer: a TMA-based immunohistochemical study on 2,197 breast cancer patients.
    Burandt E; Bari Noubar T; Lebeau A; Minner S; Burdelski C; Jänicke F; Müller V; Terracciano L; Simon R; Sauter G; Wilczak W; Lebok P
    Oncol Rep; 2014 Dec; 32(6):2628-34. PubMed ID: 25270339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALCAM, activated leukocyte cell adhesion molecule, influences the aggressive nature of breast cancer cells, a potential connection to bone metastasis.
    Davies S; Jiang WG
    Anticancer Res; 2010 Apr; 30(4):1163-8. PubMed ID: 20530423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
    Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
    Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
    Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K
    Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA expression profiling and the role of ALCAM modulating tumor growth and metastasis in benzo[a]pyrene-transformed 16HBE cells.
    Li L; Chen J; Wang Y; Zhou C; Ma X; Fu J; Yao B; Zhao P
    Toxicology; 2020 Sep; 442():152539. PubMed ID: 32681969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of activated leukocyte cell adhesion molecule in breast cancer. Predictability of the response to taxane-free chemotherapy].
    Kilic E; Milde-Langosch K; Müller V; Wirtz R; Ihnen M
    Pathologe; 2008 Nov; 29 Suppl 2():347-52. PubMed ID: 18810438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-214 and miR-148b Targeting Inhibits Dissemination of Melanoma and Breast Cancer.
    Orso F; Quirico L; Virga F; Penna E; Dettori D; Cimino D; Coppo R; Grassi E; Elia AR; Brusa D; Deaglio S; Brizzi MF; Stadler MB; Provero P; Caselle M; Taverna D
    Cancer Res; 2016 Sep; 76(17):5151-62. PubMed ID: 27328731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-125b targets ARID3B in breast cancer cells.
    Akhavantabasi S; Sapmaz A; Tuna S; Erson-Bensan AE
    Cell Struct Funct; 2012; 37(1):27-38. PubMed ID: 22307404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of microRNA-125b expression in MCF7 breast cancer cells by ATR-FTIR spectroscopy.
    Ozek NS; Tuna S; Erson-Bensan AE; Severcan F
    Analyst; 2010 Dec; 135(12):3094-102. PubMed ID: 20978686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The carboxy-terminal domain of connexin 43 (CT-Cx43) modulates the expression of p53 by altering miR-125b expression in low-grade human breast cancers.
    Maqbool R; Rashid R; Ismail R; Niaz S; Chowdri NA; Hussain MU
    Cell Oncol (Dordr); 2015 Dec; 38(6):443-51. PubMed ID: 26335100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of miR-630 Induced by Oxidative Damage Resists Cell Migration Through Targeting ALCAM in Human Lens Epithelium Cells.
    Mei L; Yan H; Wang S; Guo C; Zheng X; Yan B; Zhao J; Yang A
    Curr Eye Res; 2020 Feb; 45(2):153-161. PubMed ID: 31869263
    [No Abstract]   [Full Text] [Related]  

  • 14. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of activated leukocyte cell adhesion molecule in the serum of breast cancer patients and implications for prognosis.
    Witzel I; Schröder C; Müller V; Zander H; Tachezy M; Ihnen M; Jänicke F; Milde-Langosch K
    Oncology; 2012; 82(6):305-12. PubMed ID: 22555284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of miR-125b-mitochondria-caspase-3 pathway in doxorubicin resistance and therapy in human breast cancer.
    Xie X; Hu Y; Xu L; Fu Y; Tu J; Zhao H; Zhang S; Hong R; Gu X
    Tumour Biol; 2015 Sep; 36(9):7185-94. PubMed ID: 25894378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer.
    Ihnen M; Müller V; Wirtz RM; Schröder C; Krenkel S; Witzel I; Lisboa BW; Jänicke F; Milde-Langosch K
    Breast Cancer Res Treat; 2008 Dec; 112(3):419-27. PubMed ID: 18172759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-214 coordinates melanoma progression by upregulating ALCAM through TFAP2 and miR-148b downmodulation.
    Penna E; Orso F; Cimino D; Vercellino I; Grassi E; Quaglino E; Turco E; Taverna D
    Cancer Res; 2013 Jul; 73(13):4098-111. PubMed ID: 23667173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Impact of Activated Leucocyte Cell Adhesion Molecule (ALCAM/CD166) in Infantile Neuroblastoma.
    Wachowiak R; Mayer S; Kaifi J; Gebauer F; Izbicki JR; Lacher M; Bockhorn M; Tachezy M
    Anticancer Res; 2016 Aug; 36(8):3991-5. PubMed ID: 27466504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-α, CCNJ, and MEGF9.
    Feliciano A; Castellvi J; Artero-Castro A; Leal JA; Romagosa C; Hernández-Losa J; Peg V; Fabra A; Vidal F; Kondoh H; Ramón Y Cajal S; Lleonart ME
    PLoS One; 2013; 8(10):e76247. PubMed ID: 24098452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.